Select pharma shares rally; Neuland Laboratories hits lifetime high

Neuland Lab, Wockhardt, Suven Life Sciences, Unichem Lab and Indoco Remedies gained between 3%-17% on the BSE.

Select pharma shares rally; Neuland Laboratories hits lifetime high
SI Reporter Mumbai
Last Updated : Sep 10 2015 | 12:57 PM IST
Shares of select pharmaceutical companies have rallied by up to 17% on the bourses in otherwise weak market.

Neuland Laboratories, Wockhardt, Suven Life Sciences, Unichem Laboratories and Indoco Remedies have rallied between 3%-17% on the BSE. At 12:39 PM, the S&P BSE Sensex was down 0.76% at 25,523 points.

Wockhardt has moved higher by 9% to Rs 1,323, extending its previous 2% gain on the BSE, after drug maker said it has received approval for Memantine hydrochloride tablets from United States Food and Drug Administration (USFDA).

Suven Life Sciences rallied 7% to Rs 221 after the company secured five product patents in China, Israel, Mexico, Singapore and Sri Lanka ) corresponding to their New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases.

Neuland Laboratories has soared 17% to Rs 716, also its lifetime high on the BSE. The stock of pharmaceutical firm rallied 39% from Rs 506 on August 13, post June quarter results. The S&P BSE Sensex was down 7.4% during the same period.

The company had reported more than doubled standalone net profit at Rs 7.3 crore for the quarter ended June 30, 2015 (Q1FY16), on the back of strong operational performance. It had a profit of Rs 3 crore in the same quarter a year ago.

Earnings before interest, tax, depreciation and amortization (EBITDA) margins improved 360 basis points Y-o-Y to 17.6% in Q1FY16 as against 14.0% in Q1FY15.
 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 10 2015 | 12:54 PM IST

Next Story